Do we need early risk stratification after ST-elevation myocardial infarction?

Peter McLeod^{1

2}, Philip D Adamson^{3

4}, Sean Coffey^{5

2}

Affiliations

¹ Department of Medicine - HeartOtago, University of Otago Dunedin School of Medicine, Dunedin, New Zealand.
² Department of Cardiology, Southern District Health Board, Dunedin, New Zealand.
³ Christchurch Heart Institute, University of Otago Christchurch, Christchurch, New Zealand.
⁴ British Heart Foundation Centre for Cardiovascular Science, The University of Edinburgh, Edinburgh, UK.
⁵ Department of Medicine - HeartOtago, University of Otago Dunedin School of Medicine, Dunedin, New Zealand scoffey@doctors.org.uk.

Editorial

Peter McLeod et al. Heart. 2021 Dec.

. 2021 Dec;107(23):1852-1853.

doi: 10.1136/heartjnl-2021-320030. Epub 2021 Sep 20.

Peter McLeod^{1

2}, Philip D Adamson^{3

4}, Sean Coffey^{5

2}

¹ Department of Medicine - HeartOtago, University of Otago Dunedin School of Medicine, Dunedin, New Zealand.
² Department of Cardiology, Southern District Health Board, Dunedin, New Zealand.
³ Christchurch Heart Institute, University of Otago Christchurch, Christchurch, New Zealand.
⁴ British Heart Foundation Centre for Cardiovascular Science, The University of Edinburgh, Edinburgh, UK.
⁵ Department of Medicine - HeartOtago, University of Otago Dunedin School of Medicine, Dunedin, New Zealand scoffey@doctors.org.uk.

No abstract available

Keywords: biomarkers; echocardiography; myocardial infarction.

Conflict of interest statement

Competing interests: None declared.

Prognostic value of admission high-sensitivity troponin in patients with ST-elevation myocardial infarction.
Coelho-Lima J, Georgiopoulos G, Ahmed J, Adil SER, Gaskin D, Bakogiannis C, Sopova K, Ahmed F, Ahmed H, Spray L, Richardson G, Bagnall AJ, Stellos K, Stamatelopoulos K, Spyridopoulos I. Coelho-Lima J, et al. Heart. 2021 Dec;107(23):1881-1888. doi: 10.1136/heartjnl-2021-319225. Epub 2021 Sep 20. Heart. 2021. PMID: 34544804